2013
DOI: 10.2147/opth.s45248
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice

Search citation statements

Order By: Relevance

Paper Sections

Select...
49
23
22
0

Citation Types

3
91
0
3

Year Published

Range
2014
2014
2026
2026

Publication Types

Select...
83
6
1

Relationship

0
90

Authors

Journals

citations

Cited by 90 publications

(97 citation statements)
references

References 27 publications

3
91
0
3
Order By: Relevance
How this paper cites the one you are viewing
“…In our series, we found that the baseline NEI-VFQ-25 composite score in our population was 82.14, which is higher than the results of previous studies (68.0–79.4) including the MARINA and ANCHOR trials [17,23,28,29,30,31]. Our results complement previous studies in other populations such as that of Oshima et al [17].…”
Section: Discussion
supporting
confidence: 82%
“…Our data show that treatment of nAMD significantly improves QoL regardless of clinical response and that this improvement is clinically significant with mean gains in NEI-VFQ 25 total scores exceeding the 4-point threshold established for nAMD [ 12 , 29 , 32 , 33 ]. Most of this improvement occurs during the loading phase, with slower gains during the extension phase.…”
Section: Discussion
mentioning
confidence: 64%
See 1 more Smart Citation